Trials / Conditions / Leukemia, B-Cell, Chronic
Leukemia, B-Cell, Chronic
6 registered clinical trials studyying Leukemia, B-Cell, Chronic — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Stand NCT07082452 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 3 |
| Completed | Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL NCT00546793 | Gilead Sciences | Phase 1 / Phase 2 |
| Completed | Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients NCT00559624 | Advancell - Advanced In Vitro Cell Technologies, S.A. | Phase 1 / Phase 2 |
| Completed | A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia NCT00419250 | Celgene | Phase 1 |
| Completed | Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocyt NCT00344825 | Genzyme, a Sanofi Company | — |
| Completed | Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells NCT00078520 | Baylor College of Medicine | Phase 1 |